Full coverage· Health· Updated
Israeli Study Links Weight-Loss Drugs to Lower Dementia Risk
An Israeli study of nearly 47,000 patients found that GLP-1 drugs, used for diabetes and obesity, were associated with a 14% lower risk of dementia compared to other diabetes treatments. The research, involving adults with type 2 diabetes and obesity, also noted stronger links in women and older adults.
2 newsrooms · 1 language · sincePlus
What happened
- 01Israeli study links GLP-1 drugs to 14% lower dementia risk in diabetes and obesity patients.
- 02Research involved nearly 47,000 Clalit Health Services patients with type 2 diabetes and obesity.
- 03Dementia risk reduction was more pronounced in women (22%) and older adults (18%).
- 04The benefit was specifically noted compared to older sulfonylurea diabetes drugs.
- 05Researchers caution that the observational study cannot prove causation and more trials are needed.
While promising, researchers emphasize that the observational study cannot prove causation and further clinical trials are needed. The findings suggest potential brain health benefits beyond weight and sugar control.
The coverage
2 newsrooms on this story
Who covered it
- LeftNone
- Centre1
- Right1
- HarediNone
- ArabNone
How it broke
See which of the 2 newsrooms broke it, and who waited